Skip to main content
. Author manuscript; available in PMC: 2019 Jan 25.
Published in final edited form as: Vaccine. 2017 Dec 14;36(4):438–441. doi: 10.1016/j.vaccine.2017.12.017

Fig. 1.

Fig. 1

Activation of HSV-2 gB-specific CD8+ T cells by immunization with peptide-nanofiber vaccine adjuvanted with CpG or Gardiquimod. A. Detection of HSV-2 gB-specific CD8+ T cells by flow cytometry. B. HSV-2 gB-specific response in draining lymph nodes on day eight following primary peptide-nanofiber immunization. Results shown are pooled from two experiments of identical design. * P < .05 one way ANOVA.